Literature DB >> 16019436

GAPs in growth factor signalling.

Andre Bernards1, Jeffrey Settleman.   

Abstract

Approximately 2% of genes predicted by the sequenced human genome encode small GTPases and their regulators, highlighting the biological significance of regulated GTPase activity. Among the key GTPase regulators are the GTPase activating proteins (GAPs), which function to down-modulate active GTPases. Of the numerous identified GAPs, several have been implicated in signal transduction downstream of growth factors. In particular, GAPs for the Ras and Rho GTPases, which mediate a variety of receptor-transduced signals, appear to play an essential role in growth factor dependent GTPase regulation. Experimental studies of several of the GAPs have begun to elucidate mechanisms by which GAP activity is influenced by growth factor signaling, including direct phosphorylation, sub-cellular redistribution and protein degradation. Here, some of these mechanisms of GAP regulation in the context of signaling responses to growth factors are reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019436     DOI: 10.1080/08977190500130480

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  29 in total

1.  The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation.

Authors:  Hideaki Naoe; Kimi Araki; Osamu Nagano; Yusuke Kobayashi; Jo Ishizawa; Tatsuyuki Chiyoda; Takatsune Shimizu; Ken-ichi Yamamura; Yutaka Sasaki; Hideyuki Saya; Shinji Kuninaka
Journal:  Mol Cell Biol       Date:  2010-06-07       Impact factor: 4.272

Review 2.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 3.  Bookmarking the genome: maintenance of epigenetic information.

Authors:  Sayyed K Zaidi; Daniel W Young; Martin Montecino; Andre J van Wijnen; Janet L Stein; Jane B Lian; Gary S Stein
Journal:  J Biol Chem       Date:  2011-03-24       Impact factor: 5.157

Review 4.  Ras-Specific GTPase-Activating Proteins-Structures, Mechanisms, and Interactions.

Authors:  Klaus Scheffzek; Giridhar Shivalingaiah
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

5.  Genotyping of cutaneous melanoma.

Authors:  Isabella C Glitza; Michael A Davies
Journal:  Chin Clin Oncol       Date:  2014-09

6.  Down's-syndrome-related kinase Dyrk1A modulates the p120-catenin-Kaiso trajectory of the Wnt signaling pathway.

Authors:  Ji Yeon Hong; Jae-Il Park; Moonsup Lee; William A Muñoz; Rachel K Miller; Hong Ji; Dongmin Gu; Jerome Ezan; Sergei Y Sokol; Pierre D McCrea
Journal:  J Cell Sci       Date:  2012-02-01       Impact factor: 5.285

7.  RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway.

Authors:  Hong Chen; Zheng-Yuan Cheng; Ying Pan; Zhi Wang; Yang Liu; Jin-Qi Zhang
Journal:  Hum Cell       Date:  2014-02-15       Impact factor: 4.174

8.  The BNIP-2 and Cdc42GAP homology (BCH) domain of p50RhoGAP/Cdc42GAP sequesters RhoA from inactivation by the adjacent GTPase-activating protein domain.

Authors:  Yi Ting Zhou; Li Li Chew; Sheng-cai Lin; Boon Chuan Low
Journal:  Mol Biol Cell       Date:  2010-07-21       Impact factor: 4.138

9.  DLC1 activation requires lipid interaction through a polybasic region preceding the RhoGAP domain.

Authors:  Patrik Erlmann; Simone Schmid; Florian A Horenkamp; Matthias Geyer; Thomas G Pomorski; Monilola A Olayioye
Journal:  Mol Biol Cell       Date:  2009-08-26       Impact factor: 4.138

10.  Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation.

Authors:  D Raepple; F von Lintig; T Zemojtel; M Duchniewicz; A Jung; M Lübbert; G R Boss; J S Scheele
Journal:  Ann Hematol       Date:  2008-09-11       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.